Feedback / Questions
pelacarsen (AKCEA-APO(a)-LRx) - Novartis
https://www.globenewswire.com/news-release/2026/09/04/3356808/0/en/novartis-announces-lp-a-horizon-phase-iii-topline-results-for-pelacarsen-in-patients-with-elevated-lp-a-and-established-cardiovascular-disease-cvd.html
Sep 4, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next